More on INSM
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $121.82 |
|
|||
| Open | $121.95 | ||||
| 52 Wk High | $19.30 | ||||
| 52 Wk Low | $9.02 | ||||
| Day High | $122.19 | ||||
| Day Low | $119.52 | ||||
| P/E | N/A | ||||
| EPS | $-1.69 | ||||
| Volume | 1,419,253 | ||||
- Insmed to Present at September 2026 Investor Conferences
- Form 4 INSMED Inc For: Aug 17 Filed by: SHAROKY MELVIN MD
- Insmed (INSM) PT Raised to $195 at Mizuho
- Japan approves Insmed's Brinsupri for lung disease treatment
- BRINSUPRI® (brensocatib) Approved by Japan's Ministry of Health, Labour and Welfare for the Treatment of Patients With Non-Cystic Fibrosis Bronchiectasis, a Serious, Chronic Lung Disease
- Form 4 INSMED Inc For: Aug 17 Filed by: SHAROKY MELVIN MD
- Form 144 INSMED Inc Filed by: SHAROKY MELVIN MD
- Form SCHEDULE 13G/A INSMED Inc Filed by: Darwin Global Management, Ltd.
- Form 4 INSMED Inc For: Aug 10 Filed by: Adsett Roger
- Form 144 INSMED Inc Filed by: Adsett Roger
Entities mentioned with INSM
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- 13G | View Related Stories »
- Definitive Agreement | View Related Stories »
- Stifel | View Related Stories »
- Show More...
